Comparison of Mitral Valve Repair Versus Percutaneous Mitral Balloon Commissurotomy for Patients With Rheumatic Heart Disease: A Single-Centre Study
Heart, Lung and Circulation · 2024
DOI: 10.1016/j.hlc.2024.05.005 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Heart, Lung and Circulation, 2024. Verfasst von Xin Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery Center, Beijing Anzhen Hospital, Beijing Institute of Heart, Lung, and Blood Vascular Diseases, Capital Medical Univers…. Hauptthemen laut MEDLINE: Rheumatic Heart Disease, Mitral Valve Stenosis, Mitral Valve. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Percutaneous mitral balloon commissurotomy (PMBC) is the standard treatment option for patients with rheumatic mitral stenosis (MS), according to current guidelines. This study aimed to compare the outcomes of rheumatic mitral valve repair (rMVR) and PMBC in this patient population. METHODS: Baseline, clinical, and follow-up data from 703 patients with rheumatic heart disease who underwent PMBC or rMVR at the current centre were collected and analysed. A 1:1 propensity score (PS) matching method was used to balance the differences in baseline characteristics between the two groups. The primary outcome was mitral valve reoperation, and the secondary outcome was all-cause mortality. RESULTS: Propensity score matching generated 101 patient pairs for comparison. In the matched population, there were no significant differences in the early clinical outcomes between the groups. The median follow-up time was 40.9 months. Overall, patients in the rMVR group had a statistically significantly lower risk of mitral valve reoperation than those in the PMBC group (HR 0.186; 95% CI 0.041-0.835; p=0.028). Regarding all-cause mortality, no statistically significant differences were observed between the rMVR and PMBC groups (HR 4.065; 95% CI 0.454-36.374; p=0.210). CONCLUSIONS: Compared with PMBC, rMVR has more advantages for the correction of valve lesions; therefore, it may offer a better prognosis than PMBC in select patients with rheumatic MS. However, this finding needs to be verified in future studies with larger sample sizes and longer follow-up periods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac Surgery Center, Beijing Anzhen Hospital, Beijing Institute of Heart, Lung, and Blood Vascular Diseases, Capital Medical University, Beijing, China.
- Department of Cardiac Surgery Center, Beijing Anzhen Hospital, Beijing Institute of Heart, Lung, and Blood Vascular Diseases, Capital Medical University, Beijing, China. Electronic address: dr.dragonfly@outlook.com.
- Department of Cardiovascular Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China. Electronic address: ayfylyy@163.com.
- Department of Cardiac Surgery Center, Beijing Anzhen Hospital, Beijing Institute of Heart, Lung, and Blood Vascular Diseases, Capital Medical University, Beijing, China. Electronic address: azzhanghj@163.com.
Zitieren
APA
Li, X., Zhu, Y., Liang, J., Jiang, W., Han, J., Wang, L., Liu, Y., & Zhang, H. (2024). Comparison of Mitral Valve Repair Versus Percutaneous Mitral Balloon Commissurotomy for Patients With Rheumatic Heart Disease: A Single-Centre Study. Heart, Lung and Circulation. https://doi.org/10.1016/j.hlc.2024.05.005
Vancouver
Li X, Zhu Y, Liang J, Jiang W, Han J, Wang L, et al. Comparison of Mitral Valve Repair Versus Percutaneous Mitral Balloon Commissurotomy for Patients With Rheumatic Heart Disease: A Single-Centre Study. Heart, Lung and Circulation. 2024. doi:10.1016/j.hlc.2024.05.005
BibTeX
@article{Li2024,
author = {Li, Xin and Zhu, Yinfan and Liang, Jiajun and Jiang, Wenjian and Han, Jie and Wang, Longfei and Liu, Yuyong and Zhang, Hongjia},
title = {Comparison of Mitral Valve Repair Versus Percutaneous Mitral Balloon Commissurotomy for Patients With Rheumatic Heart Disease: A Single-Centre Study},
journal = {Heart, Lung and Circulation},
year = {2024},
doi = {10.1016/j.hlc.2024.05.005}
}
EUVIMED